Categories Proteins & Peptides
IL-33 is suitable as a control for polyclonal or monoclonal anti-IL-33 in immunological assays.
IL-32A is suitable as a control for polyclonal or monoclonal anti-IL-32A in immunological assays.
IL-3 is suitable as a control for polyclonal or monoclonal anti-IL-3 in immunological assays.
IL-3 is suitable as a control for polyclonal or monoclonal anti-IL-3 in immunological assays.
IL-29 is suitable as a control for polyclonal or monoclonal anti-IL-29 in immunological assays.
IL-27/p28 is suitable as a control for polyclonal or monoclonal anti-IL-27/p28 in immunological assays.
IL-27/p28 is suitable as a control for polyclonal or monoclonal anti-IL-27/p28 in immunological assays.
IL-2 is suitable as a control for polyclonal or monoclonal anti-IL-2 in immunological assays.
Interleukin-1beta (IL-1(B)) is suitable as a control for polyclonal or monoclonal anti-Interleukin-1beta (IL-1(B)) in immunological assays.
Interleukin-1beta (IL-1(B)) is suitable as a control for polyclonal or monoclonal anti-Interleukin-1beta (IL-1(B)) in immunological assays.
Interleukin-1beta (IL-1(B)) is suitable as a control for polyclonal or monoclonal anti-Interleukin-1beta (IL-1(B)) in immunological assays.
IL-17F is suitable as a control for polyclonal or monoclonal anti-IL-17F in immunological assays.
IL-17F is suitable as a control for polyclonal or monoclonal anti-IL-17F in immunological assays.
IL-17F is suitable as a control for polyclonal or monoclonal anti-IL-17F in immunological assays.
IL-17A is suitable as a control for polyclonal or monoclonal anti-IL-17A in immunological assays.
IL-17A is suitable as a control for polyclonal or monoclonal anti-IL-17A in immunological assays.
IL-17A is suitable as a control for polyclonal or monoclonal anti-IL-17A in immunological assays.
Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay.
Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay.
Intended for use as a control peptide when used with anti- I?B???C-terminal specific? to block specific interaction of anti- I?B???C-terminal specific? [p/n...
Get the Best Promotions
